Worth reading
41Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
191100
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数191,100Shares
191,100 new shares (no treasury shares transferred)
Intended allottee
EVO FUND (allottee at the time of issuance)
発行済株式総数
0.86% (exercise ratio subject to exercise restrictions; the ratio of the shares exercised in this transaction to the total number of shares issued is not disclosed)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price in March 2026 was ¥166–¥188. Details of the adjustment clauses and the floor price are Not disclosed
Number of Stock Acquisition Rights
Total issued: 100,000 rights; unexercised as of the end of the month preceding the month covered: 74,711 rights; unexercised as of the end of the month covered: 72,800 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Issued on 10 November 2025: 2025 Second Series of Stock Acquisition Rights with Exercise Price Adjustment Clauses. Total issued: 100,000 rights. Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 191,100 new shares (no treasury shares transferred) |
| Intended allottee | EVO FUND (allottee at the time of issuance) |
| Dilution Rate | 0.86% (exercise ratio subject to exercise restrictions; the ratio of the shares exercised in this transaction to the total number of shares issued is not disclosed) |
| Total number of issued shares | 25,813,292 shares (as of the end of the month preceding the month covered, including 78,009 treasury shares) → Not disclosed |
| Exercise price | The exercise price in March 2026 was ¥166–¥188. Details of the adjustment clauses and the floor price are Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100,000 rights; unexercised as of the end of the month preceding the month covered: 74,711 rights; unexercised as of the end of the month covered: 72,800 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 10 November 2025: 2025 Second Series of Stock Acquisition Rights with Exercise Price Adjustment Clauses. Total issued: 100,000 rights. Amount: Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of these stock acquisition rights in March 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.